Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 30, 2021
Current Assets:
Cash and cash equivalents	$ 18,998	$ 31,153
Available-for-sale securities		7,717
Accounts receivable, net of allowances of $81 and $119 as of September 30, 2022 and 2021, respectively	10,452	9,169
Contract assets — royalties and license fees	7,116	7,091
Inventories, net	11,819	6,760
Income tax receivable	2,438	1,912
Prepaids and other	6,764	6,453
Total Current Assets	57,587	70,255
Property and equipment, net	27,148	30,090
Available-for-sale securities		2,002
Deferred income taxes		5,867
Intangible assets, net	28,145	37,054
Goodwill	40,710	45,606
Other assets	4,769	3,718
Total Assets	158,359	194,592
Current Liabilities:
Accounts payable	3,136	1,783
Accrued liabilities:
Compensation	8,929	8,480
Accrued other	5,854	4,905
Short-term borrowings	10,000	10,000
Deferred revenue	4,160	4,647
Total Current Liabilities	32,079	29,815
Deferred revenue, less current portion	5,088	10,301
Deferred income taxes	2,027	2,742
Other long-term liabilities	10,773	11,649
Total Liabilities	49,967	54,507
Commitments and Contingencies (Note 11)
Stockholders’ Equity:
Series A preferred stock — $.05 par value, 450 shares authorized; no shares issued and outstanding
Common stock - $.05 par value, 45,000 shares authorized; 14,029 and 13,899 shares issued and outstanding, as of September 30, 2022 and 2021, respectively	701	695
Additional paid-in capital	28,774	21,598
Accumulated other comprehensive (loss) income	(9,874)	1,727
Retained earnings	88,791	116,065
Total Stockholders’ Equity	108,392	140,085
Total Liabilities and Stockholders’ Equity	$ 158,359	$ 194,592